Loading clinical trials...
Loading clinical trials...
A Phase 2, Fast Real-time Assessment of Combination Therapies in Immuno-ONcology Study in Participants With Advanced Gastric Cancer (FRACTION-Gastric Cancer)
Conditions
Interventions
Nivolumab
Ipilimumab
+3 more
Locations
35
United States
Mayo Clinic Arizona
Phoenix, Arizona, United States
Local Institution - 0020
Duarte, California, United States
University Of Colorado
Aurora, Colorado, United States
Local Institution - 0032
New Haven, Connecticut, United States
Local Institution - 0036
Washington D.C., District of Columbia, United States
UF Health Medical Oncology - Davis Cancer Pavilion
Gainesville, Florida, United States
Start Date
November 29, 2016
Primary Completion Date
May 11, 2022
Completion Date
May 11, 2022
Last Updated
June 9, 2023
NCT07259226
NCT07102901
NCT06767436
NCT06727981
NCT06478394
NCT06123494
Lead Sponsor
Bristol-Myers Squibb
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions